The biggest study published to date with regard to the prognostic utility of GDF-15 in CKD patients demonstrated a doubled mortality risk per 1-SD greater after adjustment, that correlates with the findings in our study [24]. The gene discussed is GDF15; the disease is chronic kidney disease.